<p><em>Acinetobacter baumannii</em> Sequence Types Harboring Genes Encoding Aminoglycoside Modifying Enzymes and 16SrRNA Methylase; a Multicenter Study from Pakistan</p>

Abstract

Introduction: The aminoglycosides are widely used for the therapeutic management of infections caused by gram-negative bacteria, including the Acinetobacter baumannii strains. However, the resistance to the members of the aminoglycoside family, such as amikacin, gentamicin, and tobramycin, is increasingly being common among the clinical isolates. Purpose: This study aimed to investigate the presence of 16SrRNA methylases and aminoglycoside modifying enzymes (AMEs) genes among aminoglycoside resistant A. baumannii isolates and to study the genetic diversity of the clinical population of A. baumannii in local hospitals. Material and Methods: The 143 A. baumannii clinical strains were analyzed for antimicrobial susceptibility, genetic screening for enzymes conferring aminoglycosides resistance followed by the multilocus sequence typing. Results: The 133/143 (93%) isolates were non-susceptible to at least one of the tested aminoglycosides, including amikacin, gentamicin, and tobramycin. The MIC distribution has shown that 87.486.7% strains were resistant to amikacin and gentamicin, respectively. The aphA6, aadB, aacC1, and aphA1 were found in 74.1%, 59.4%, 16.1%, and 11.2% isolates, respectively, whereas the armA was found in 28% of the strains having a higher MIC value (MIC; ≥256µg/mL). The MLST data have shown that the ST589 and ST2 were the most common STs and corresponded to 51 (35.7%) and 38 (26.6%) isolates, respectively, and few of the isolates corresponding to these STs were found to harbor the armA gene with a variable genotypic profile for AMEs. Discussion: The study has reported the incidence of various enzymes conferring aminoglycoside resistance among the A. baumannii clones for the first time from Pakistan. The findings suggest the possibility of transmission of aminoglycoside resistance determinants through the lateral gene transfer as well as clonal dissemination.

Bacteriophage Proteome: Insights and Potentials of an Alternate to Antibiotics

“…The stay of patients suffering from such resistant infections is approximately 13 days, which costs about $29,000/patient treated with such resistant bacterial infections. In this regard, a total annual economic loss (productivity loss) of about $35 billion has been reported [1][2][3][4]. The global nature of this issue emphasizes the need to control the antibiotic resistance crisis [1,5].…”

Efficacy of Phage-Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates

“…Antibiotic resistance is a growing health threat across the globe. Multidrug-resistant (MDR) pathogens are associated with increased morbidity and mortality and pose a substantial economic impact on the health care systems of low-and middle-income countries (LMICs) like Pakistan (1)(2)(3)(4)(5). Klebsiella pneumoniae is a well-recognized MDR pathogen, which has acquired substantial health significance in recent years.…”

The First Saudi Study Investigating the Plasmid-borne Aminoglycoside and Sulfonamide Resistance among Acinetobacter baumannii Clinical Isolates Genotyped by RAPD-PCR: the Declaration of a Novel Allelic Variant Called aac(6ʹ)-SL and Three Novel Mutations in the sul1 Gene in the Acinetobacter Plasmid (s)

“…A. baumannii was the only species in the genus Acinetobacter that intrinsically harbors bla OXA-51 which was then used for identification and differentiation of A. baumannii from the other Acinetobacter species. 4 , 5 …”